The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
NCT Number: NCT03052153
This study will evaluate if an association exists between levels of blood flow through the pulmonary veins and the incidence of graft dysfunction post operatively.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Columbus, Ohio, 43210, United States
Lung transplantation surgery can be fraught with a multitude of early as well as delayed complications leading to increased morbidity and mortality. During lung transplant surgery, trans-esophageal echocardiography (TEE) is routinely used to identify cardiac anatomy and measure blood flow through the pulmonary veins. This blood flow is assessed both before and after the lung has been transplanted. Blood flow through these small caliber vessels can be impacted by many variables with a resulting reduction in blood circulating to the lung, although currently there is no agreement on an acceptable level of flow. This study will look at retrospective data from lung transplant surgeries undertaken at this institution since Jan 1st 2014 until November 18th 2016 with the goal of determining if an association exists between levels of blood flow through the pulmonary veins and the incidence of graft dysfunction post operatively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No investigational intervention for the purpose of this study was performed; data collected is retrospective data previously collected for non-research purposes.
Time frame: at 30 days post-transplant
To describe the relationship between intra-operative pulmonary vein systolic velocities and the incidence of graft dysfunction as defined by the International Society for Heart and Lung Transplantation (ISHLT).
Time frame: at 30 days post-transplant
To describe the relationship between intra-operative pulmonary vein systolic velocities and grade of graft dysfunction as defined by the International Society for Heart and Lung Transplantation (ISHLT).
Time frame: at 30 days post-transplant
To measure and report all-cause mortality at 30 days post-transplant.
Time frame: From hospital admission to discharge up to one year.
To report subjects hospital length of stay for up to one year.
Ohio State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06125535
Cardiovascular Diseases, Lung Transplant Failure
Milan, Italy
View Trial DetailsNCT05242289
Lung Transplant Failure, Lung Transplant; Complications
Lund, Skåne County, Sweden
View Trial DetailsNCT06399302
Infections, Inflammation
Los Angeles, California, United States
View Trial DetailsNCT06259357
Lung Transplant Failure
Toronto, Ontario, Canada
View Trial Details